Achieving sustained virologic response after interferon-free hepatitis C virus treatment correlates with hepatic interferon gene expression changes independent of cirrhosis
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Achieving sustained virologic response after interferon-free hepatitis C virus treatment correlates with hepatic interferon gene expression changes independent of cirrhosis
Authors
Keywords
-
Journal
JOURNAL OF VIRAL HEPATITIS
Volume 23, Issue 7, Pages 496-505
Publisher
Wiley
Online
2016-02-04
DOI
10.1111/jvh.12510
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Ombitasvir, Paritaprevir Co-dosed With Ritonavir, Dasabuvir, and Ribavirin for Hepatitis C in Patients Co-infected With HIV-1
- (2015) Mark S. Sulkowski et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- miR-122 – A key factor and therapeutic target in liver disease
- (2015) Simonetta Bandiera et al. JOURNAL OF HEPATOLOGY
- Expression of Interferon Lambda 4 Is Associated with Reduced Proliferation and Increased Cell Death in Human Hepatic Cells
- (2015) Olusegun O. Onabajo et al. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- Virological response after 6 week triple-drug regimens for hepatitis C: a proof-of-concept phase 2A cohort study
- (2015) Anita Kohli et al. LANCET
- Sorting out cirrhosis: mechanisms of non-response to hepatitis C therapy
- (2015) Saeed H. Al Marzooqi et al. LIVER INTERNATIONAL
- Small tRNA-derived RNAs are increased and more abundant than microRNAs in chronic hepatitis B and C
- (2015) Sara R. Selitsky et al. Scientific Reports
- Addressing Bias in Small RNA Library Preparation for Sequencing: A New Protocol Recovers MicroRNAs that Evade Capture by Current Methods
- (2015) Jeanette Baran-Gale et al. Frontiers in Genetics
- The multifaceted functions of ribavirin: Antiviral, immunomodulator, or both?
- (2014) Mario U. Mondelli HEPATOLOGY
- Ribavirin improves the IFN-γ response of natural killer cells to IFN-based therapy of hepatitis C virus infection
- (2014) Jens M. Werner et al. HEPATOLOGY
- Endogenous intrahepatic IFNs and association with IFN-free HCV treatment outcome
- (2014) Eric G. Meissner et al. JOURNAL OF CLINICAL INVESTIGATION
- Restoration of HCV-specific CD8+ T cell function by interferon-free therapy
- (2014) Bianca Martin et al. JOURNAL OF HEPATOLOGY
- Post-Transcriptional Regulation of Interferons and Their Signaling Pathways
- (2014) Ram Savan JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- The role of microRNAs in Hepatitis C Virus replication and related liver diseases
- (2014) Chang Ho Lee et al. JOURNAL OF MICROBIOLOGY
- Ledipasvir and Sofosbuvir for Previously Treated HCV Genotype 1 Infection
- (2014) Nezam Afdhal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sofosbuvir and Ribavirin in HCV Genotypes 2 and 3
- (2014) Stefan Zeuzem et al. NEW ENGLAND JOURNAL OF MEDICINE
- ABT-450/r–Ombitasvir and Dasabuvir with Ribavirin for Hepatitis C with Cirrhosis
- (2014) Fred Poordad et al. NEW ENGLAND JOURNAL OF MEDICINE
- Impaired Expression of Type I and Type II Interferon Receptors in HCV-Associated Chronic Liver Disease and Liver Cirrhosis
- (2014) Partha K. Chandra et al. PLoS One
- microRNAs: Novel players in hepatitis C virus infection
- (2014) Xiaofei Li et al. Clinics and Research in Hepatology and Gastroenterology
- Hepatitis C virus and microRNAs: miRed in a host of possibilities
- (2014) Ragunath Singaravelu et al. Current Opinion in Virology
- Efficacy of Nucleotide Polymerase Inhibitor Sofosbuvir Plus the NS5A Inhibitor Ledipasvir or the NS5B Non-Nucleoside Inhibitor GS-9669 Against HCV Genotype 1 Infection
- (2013) Edward J. Gane et al. GASTROENTEROLOGY
- Mechanism of action of ribavirin in anti-HCV regimens: new insights for an age-old question?
- (2013) Barbara Testoni et al. GUT
- Sofosbuvir and Ribavirin for Hepatitis C Genotype 1 in Patients With Unfavorable Treatment Characteristics
- (2013) Anuoluwapo Osinusi et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- microRNA control of interferons and interferon induced anti-viral activity
- (2013) Lisa M. Sedger MOLECULAR IMMUNOLOGY
- A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus
- (2013) Ludmila Prokunina-Olsson et al. NATURE GENETICS
- The favorable IFNL3 genotype escapes mRNA decay mediated by AU-rich elements and hepatitis C virus–induced microRNAs
- (2013) Adelle P McFarland et al. NATURE IMMUNOLOGY
- Sofosbuvir for Hepatitis C Genotype 2 or 3 in Patients without Treatment Options
- (2013) Ira M. Jacobson et al. NEW ENGLAND JOURNAL OF MEDICINE
- MicroRNA Expression Profiling in HCV-Infected Human Hepatoma Cells Identifies Potential Anti-Viral Targets Induced by Interferon-α
- (2013) Xiaozhen Zhang et al. PLoS One
- Interferon-λ4 (IFNL4) Transcript Expression in Human Liver Tissue Samples
- (2013) Ahmad Amanzada et al. PLoS One
- microRNA-122 Abundance in Hepatocellular Carcinoma and Non-Tumor Liver Tissue from Japanese Patients with Persistent HCV versus HBV Infection
- (2013) Carolyn Spaniel et al. PLoS One
- HCV-Induced miR-21 Contributes to Evasion of Host Immune System by Targeting MyD88 and IRAK1
- (2013) Yanni Chen et al. PLoS Pathogens
- Let-7b is a novel regulator of hepatitis C virus replication
- (2012) Ju-Chien Cheng et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Hepatitis C virus-induced up-regulation of microRNA-155 promotes hepatocarcinogenesis by activating Wnt signaling
- (2012) Yiliang Zhang et al. HEPATOLOGY
- Hepatitis C Virus Infection Modulates Expression of Interferon Stimulatory Gene IFITM1 by Upregulating miR-130A
- (2012) Joydip Bhanja Chowdhury et al. JOURNAL OF VIROLOGY
- Liver-specific microRNA-122: Biogenesis and function
- (2012) Catherine Jopling RNA Biology
- Identification of miRNomes in Human Liver and Hepatocellular Carcinoma Reveals miR-199a/b-3p as Therapeutic Target for Hepatocellular Carcinoma
- (2011) Jin Hou et al. CANCER CELL
- Hepatitis C Virus Infection and Hepatic Stellate Cell Activation Downregulate miR-29: miR-29 Overexpression Reduces Hepatitis C Viral Abundance in Culture
- (2011) Sarmistha Bandyopadhyay et al. JOURNAL OF INFECTIOUS DISEASES
- Boceprevir for Untreated Chronic HCV Genotype 1 Infection
- (2011) Fred Poordad et al. NEW ENGLAND JOURNAL OF MEDICINE
- Response-Guided Telaprevir Combination Treatment for Hepatitis C Virus Infection
- (2011) Kenneth E. Sherman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Boceprevir for Previously Treated Chronic HCV Genotype 1 Infection
- (2011) Bruce R. Bacon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Telaprevir for Retreatment of HCV Infection
- (2011) Stefan Zeuzem et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ribavirin Enhances IFN-α Signalling and MxA Expression: A Novel Immune Modulation Mechanism during Treatment of HCV
- (2011) Nigel J. Stevenson et al. PLoS One
- Ribavirin Improves Early Responses to Peginterferon Through Improved Interferon Signaling
- (2010) Jordan J. Feld et al. GASTROENTEROLOGY
- New Perspectives in MicroRNA Regulation of Innate Immunity
- (2010) Michael P. Gantier JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- Regulation of the hepatitis C virus genome replication by miR-199a
- (2008) Yoshiki Murakami et al. JOURNAL OF HEPATOLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started